Prelude Therapeutics

NASDAQ: PRLD · Real-Time Price · USD
0.88
-0.04 (-4.18%)
At close: May 02, 2025, 3:59 PM
0.92
4.70%
After-hours: May 02, 2025, 04:15 PM EDT

Prelude Therapeutics Revenue

Prelude Therapeutics reported an annual revenue of $7M, reflecting a 0% growth. For the quarter ending December 31, 2024, Prelude Therapeutics generated $4M in revenue.
Revenue (ttm)
$7M
Revenue Growth
0%
Price / Sales Ratio
13.75
Revenue / Employee
$53.44K
Employees
131
Market Cap
49.61M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.